CD274 and acute kidney injury: identified three independent risk factors for ICIs-AKI: concomitant use of proton pump inhibitors (PPI), the combined treatment with anti–CTLA-4 and anti–PD-1/PD-L1 agents, and a lower baseline eGFR (6, 39, 41).